Clinical Trials on Non Alcoholic Fatty Liver Disease in United Kingdom
Total 11379 results
-
University of VirginiaNational Center for Complementary and Integrative Health (NCCIH)CompletedFatty Liver | Non-alcoholic SteatohepatitisUnited States
-
Eli Lilly and CompanyRecruitingNon-Alcoholic Fatty Liver DiseaseUnited States, Japan
-
Immuron Ltd.CompletedNon-alcoholic Steatohepatitis (NASH)United States, Australia, Israel
-
University of North Carolina, Chapel HillNational Institute of General Medical Sciences (NIGMS)CompletedNon-alcoholic SteatohepatitisUnited States
-
Imperial College LondonNational Health Service, United KingdomTerminatedNAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited Kingdom
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Zydus Therapeutics Inc.CompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madaus IncUniversity of Pennsylvania; Beth Israel Deaconess Medical Center; University... and other collaboratorsCompletedNon-alcoholic SteatohepatitisUnited States
-
Emory UniversitySonic IncytesRecruitingNon-Alcoholic Fatty Liver Disease (NAFLD) | Metabolic Dysfunction Associated Steatotic Liver DiseaseUnited States
-
Emory UniversityCompletedNon-alcoholic Fatty-liver DiseaseUnited States
-
GI AllianceSonic IncytesNot yet recruitingNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
NorthSea Therapeutics B.V.Active, not recruitingNon Alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Inventiva PharmaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
-
National Human Genome Research Institute (NHGRI)TerminatedLiver Cirrhosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steato-HepatitisUnited States
-
Regeneron PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Brazil, United States, Puerto Rico, Korea, Republic of, Mexico
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited States, Spain, France, United Kingdom, Germany
-
The University of Texas Health Science Center at...National Institutes of Health (NIH); Takeda Pharmaceuticals North America,...CompletedNonalcoholic SteatohepatitisUnited States
-
Galectin Therapeutics Inc.CompletedNon-Alcoholic Steatohepatitis (NASH)United States
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Sonic IncytesActive, not recruitingLiver Fibroses | Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH) | Liver SteatosesUnited States
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
AdventHealth Translational Research InstituteActive, not recruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Emory UniversityGemphire TherapeuticsTerminated
-
Novartis PharmaceuticalsCompletedNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Washington University School of MedicineEnrolling by invitationNon-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.UnknownNon-alcoholic SteatohepatitisUnited States
-
Virginia Commonwealth UniversityWithdrawnObesity | Non-Alcoholic Fatty Liver Disease | Fatty Liver, NonalcoholicUnited States
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
Regeneron PharmaceuticalsRecruitingHealthy Volunteers | Non-alcoholic Fatty Liver Disease (NAFLD)United States
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Ireland, Belgium, Romania, Germany, Russian... and more
-
University of MinnesotaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Rockefeller UniversityNational Institutes of Health (NIH); Weill Medical College of Cornell UniversityCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Medical College of WisconsinWithdrawnObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
University of NottinghamRecruitingFatty Liver | Nutritional and Metabolic DiseaseUnited Kingdom
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Washington University School of MedicineCompletedNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
University of Illinois at ChicagoEnrolling by invitationObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
University of Illinois at ChicagoTerminatedNonalcoholic Steatohepatitis (NASH) | Hepatic SteatosisUnited States